Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Care Cluster 16: Dual Diagnosis Description: This group of patients have enduring moderate to severe psychotic or affective symptoms with unstable, chaotic lifestyles related to their mental health and coexisting problem drinking or drug use. They may present a risk to self and others and engage poorly with services. Role functioning is often impaired. Moderate to severe risk to both self and others due to violent and aggressive behaviour. Difficult to engage and maintain in services. Clients presenting with other diagnosis including personality disorder, including presentation with substance misuse. Review period: 6 monthly Cluster Duration: 3 years plus. Aim of Intervention: Treatment and risk management in clients with dual diagnosis Assessment: Comprehensive MDT assessment of Health and Social Care needs-including physical, social ,substance misuse and mental health risk assessment with due care given to safeguarding and vulnerability issues (CPA assessment tool). Comprehensive assessment of substance misuse, risks, physical and mental health symptoms as a result. Assessment to identify current coping strategies for managing distress and dealing with difficulties. Understand the emotional impact of substances on symptoms and individual experiences. Assessment process may last up to 6 weeks. (This template should be read in conjunction with latest Mental Health Clustering booklet Version 3.0 2013/14) 1: Treatment Planning Function Core Interventions Resource Time Frequency Outcome (Delivered by appropriate professional/ professionals) 1 hour 2 - 3 sessions (recorded via MDT meetings or face to face meetings) All patients will be screened for CPA and for substance misuse. Ensure assessment complete including symptoms in relation to substance misuse include assessment for emergency/planned detoxification, dependence. Assess levels of engagement Allocate care co-ordinator Review risk- identify coping strategies and strengths for managing distress and dealing with difficulties/ risk in direct and indirect relation to substance misuse (safety/vulnerability/physical health needsscreening for Hepatitis B, C and HIV, substance use Bio-psycho-social formulation Assessing co-morbidity relating to substance misuse Check co morbidity relating to personality disorder Diagnosis or formulation MDT discussions and joint assessments Medication review for both psychosis and substance misuse management / Metabolic monitoring Choice of treatments, plan, review predict and evaluate Safeguarding Assessment of carer / family (including dependents) needs and signpost where appropriate Social/housing/benefits support Legal support if under MHA Clarify goals for patient Assess need for acute inpatient care pathway, including for detoxification or referral to substance misuse rehabilitation bed Medical care- medication choice/ review for psychosis and substance misuse/metabolic monitoring; physical health checks and health Other disciplines may be involved according to clinical presentation e.g. Care Coordinator Psychiatrist Nurse Clinical psychologist STAR worker OT Social Worker Trainee/student with supervision Dual diagnosis/substance team Other professional or agency Provided patient information leaflet about diagnosis and substance misuse Morgan Risk Assessment completed Provided with care plan Patients offered choice of: Medication (different types) (Provide information leaflet on medication/ Ward information booklet, where appropriate) Psychological interventions (where appropriate) Substance misuse interventions where appropriate Substitute prescribing Carers assessment where appropriate/identification of codependency Offered copying correspondence where appropriate FINAL 10.9.13 - 1 2: Delivery Function promotion/annual health and other screening checks including screening for substance misuse. Review patients under MHA as per clinical need and legal requirements Joint working with other providers Core Interventions Care plan in line with CPA, and care coordination Identify goals Physical health and well-being interventions Support and facilitating engagement and attendance for appointments for physical health/ other services Relapse prevention and develop crisis and contingency plans On-going assessments – risk/capacity/safeguarding etc. Assessment of carer / family (including dependents) needs and signpost where appropriate Substance misuse advice: Referral to dual diagnosis team ; drug and alcohol services as appropriate engagement in group work and day programmes for substance misuse Resource Time Frequency Outcome Compliance with NICE (Delivered by appropriate professional/ professionals) 1 hour per week Once a week to once a fortnight All patients will be on CPA Provide updated care plan Care Coordinator Psychiatrist Nurse Clinical psychologist STAR worker OT Social Worker Compliance with NICE guidance 6 Monthly: HoNOS and cluster review Service user experience questionnaire Carer experience Questionnaire (if appropriate) Patients provided choice for bio-psycho-social interventions Trainee/student with supervision Dual diagnosis or staff from drug and alcohol services Compliance with NICE Supplementary Interventions Psychological care- PSI interventions, direct and indirect psychological input including psychological therapies such as CBT, family therapies- systemic; psychodynamic and motivational interviewing Social care- benefits/housing/educational/ vocational/occupational needs to be addressed Addressing concerns with regards to environment ADL/OT assessments Personalised budgets as needed Liaise with team members for review as appropriate including social services to ensure assessment of accommodation needs Family intervention Religious/cultural/spiritual needs as needed Neuropsychological and cognitive assessments as required Relapse prevention around substance misuse Review patients under MHA as per clinical need and legal requirements Joint working with other providers Referral to other mental health services as needed (e.g. forensic) Referral to SpA and In- patient treatment where appropriate Other professional or agency As required Admission to hospital FINAL 10.9.13 - 2 3: Review (in line with CPA policy) Function Core Interventions Resource Time Frequency Outcome Review patients’ strengths, achievements and goals in line with recovery model Symptom rating scales Biopsychosocial review Cluster review Risk review Employment/Accommodation Contingency planning Carer review 3rd Sector on-going support Residential care and support Specialist placement DOLS , advance decisions Substance misuse rating scales and tools Substance misuse prescribing Substance use residential rehabilitation (Delivered by appropriate professional/ professionals) 1-2 hours/ meetin g 6 monthly or earlier as required Completed cluster review Transfer to different cluster pathway provider- including advance planning/joint working as needed Manage ending and transition Signposting for extended support Re engagement discussed Sign posting for on-going carer support (Delivered by appropriate professional/ professionals) 4: Next steps Care Coordinator Psychiatrist Nurse Non- medical prescriber Clinical psychologist STAR worker OT Social Worker Trainee/student with supervision Dual diagnosis or staff from drug and alcohol services Other professional or agency as needed Care Coordinator Psychiatrist Nurse Non- medical prescriber Clinical psychologist STAR worker OT Social Worker Trainee/student with supervision Updated care plan and risk assessment Service user satisfaction questionnaire Sharing of care plan with service user/carers As per clinical need As per clinical need Outcome scales (where appropriate) HoNOS TOPS SADQ DAST AUDIT Satisfaction and feedback questionnaire Handover CPA Other agency and professionals as needed FINAL 10.9.13 - 3